Table on assessment times for Concerned Member State cases in 2021

Updated 16 February 2022

Table 1. Concerned member state cases

Concerned member state cases Average assessment time Target days Difference between assessment time and target days No. of cases measured
No. of drug IDs		 No. of cases within 30 days Share of cases within 30 days per cent
1st quarter 2020 19  30  -11  50  49  98 
2nd quarter 2020 22  30  -8 75 65 87
3rd quarter 2020
 30 30  0 89 60 67
4th quarter 2020
 32 30  2 73 57 78
1st quarter 2021 25 30  -5 37 30 81
2nd quarter 2021 62 30  32 53 22 42
3rd quarter 2021 67 30  37 151 72 48
4th quarter 2021 55 30  25 57 35 61

Tabel 2. Concerned member state cases - Human medicines

Concerenced member state cases - HUM Average assessment time Target days Difference between assessment time and target days No. of cases measured
No. of drug IDs		 No. of cases within 30 days Share of cases within 30 days per cent
1st quarter 2020
 21  30  -9  35  34  97 
2nd quarter 2020
 20  30  -10 64 57 89
3rd quarter 2020
 30 30  0 77 54 70
4th quarter 2020
 30 30  0  61 51 84
1st quarter 2021 25 30  -5 26 23  88
2nd quarter 2021 66 30  36 46 18 39
3rd quarter 2021 64 30  34 142  70 49
4th quarter 2021 50 30  20 46 33 72

Tabel 3. Concerned member state cases - Veterinary medicines

Concerenced member state cases - VET Average assessment time Target days Difference between assessment time and target days No. of cases measured
No. of drug IDs		 No. of cases within 30 days Share of cases within 30 days per cent
1st quarter 2020
 14  30  -16  15  15  100 
2nd quarter 2020
 33 30  3 11  8 73 
3rd quarter 2020
 31 30  1 12 6 50
4th quarter 2020
 45 30  15 12 6 50
1st quarter 2021 26 30  -4 11 7 64
2nd quarter 2021 38  30  8 7 4 57
3rd quarter 2021 99 30  69 9 2 22
4th quarter 2021 77 30 47 11 2 18